vaccines

News

Novavax investor withdraws proxy fight after Sanofi deal

Shah Capital Management has withdrawn a proxy campaign against the re-election of directors at vaccines firm Novavax in the wake of its $1.2 billion alliance with Sanofi.

R&D

Overcoming challenges with maternal vaccine trials

Childhood vaccines have proven to be one of the most effective public health interventions to reduce infant and child mortality.

News

FDA delays decision on Moderna’s RSV vaccine

Moderna’s first attempt to expand its commercial activities beyond COVID-19 vaccines, its respiratory syncytial virus (RSV) shot, has suffered a delay in the US.

News

Sanofi forges $1.2bn alliance with vaccines firm Novavax

Sanofi has licensed joint commercial rights to Novavax’s COVID-19 vaccine and will work with the biotech on the development of combined flu/COVID shots in a deal worth up

News

Novavax's chief executive John Jacobs (l) and Shah Capital's founder Himanshu Shah (r)

Activist investor urges changes to Novavax board

Shah Capital has stepped up its campaign for change at vaccine producer Novavax, lobbying against the re-election of three directors and executive pay packages in a letter

News

GSK trails after Pfizer in 5-in-1 meningococcal vaccine race

The FDA has started a review of GSK’s five-in-one meningococcal vaccine, cueing up a decision in mid-February next year, as it tries to chase down a rival candidate from P

Novavax investor withdraws proxy fight after Sanofi deal

Overcoming challenges with maternal vaccine trials

FDA delays decision on Moderna’s RSV vaccine

Sanofi forges $1.2bn alliance with vaccines firm Novavax

Activist investor urges changes to Novavax board

GSK trails after Pfizer in 5-in-1 meningococcal vaccine race

CDC panel votes to scrap hepatitis B birth dose advice

How to meet your physicians where they are online

vaccines

Editor's Picks